Cancer stem cells (CSCs) are a subpopulation with the properties of extensive self-renewal, capability to generate differentiated cancer cells and resistance to therapies. We have previously shown that malignant pleural effusions (MPEs) from patients with non-small-cell lung cancer (NSCLC) represent a valuable source of cancer cells that can be grown as three-dimensional (3D) spheroids enriched for stem-like features, which depend on the activation of the Yes-associated protein-transcriptional coactivator with PDZ-binding motif (YAP-TAZ)/Wnt-βcatenin/stearoyl-CoA desaturase 1 (SCD1) axis. Here, we describe a novel support, called CytoMatrix, for the characterization of limited amounts of cancer cells isolated from MPEs of patients with NSCL...
Small cell lung cancer (SCLC) is treated as a homogeneous disease, although the expression of NEUROD...
Small Cell Lung Cancer (SCLC) is a devastating disease characterized by a very low two-year survival...
Small cell lung cancer (SCLC) patient-derived xenografts (PDX) can be generated from biopsies or cir...
Background: Cancer stem cells (CSCs) are thought to be responsible for tumor regeneration after chem...
Identification of the cellular and molecular aspects of lung cancer stem cells (LCSCs) that are sugg...
In recent years, studies of cancer development and recurrence have been influenced by the cancer ste...
The lack of inadequate preclinical models remains a limitation for cancer drug development and is a ...
Knowledge on the molecular mechanisms underlying metastasis colonization in Non-Small Cell Lung Canc...
Recent evidences suggest that stearoyl-CoA-desaturase 1 (SCD1), the enzyme involved in monounsaturat...
In recent years studies of cancer development and recurrence have been significantly influenced by t...
Breast cancer tumors display different cellular phenotypes. A growing body of evidence points toward...
Cancer stem cell (CSC) theory states that tumors are organized in a similar hierarchical manner as n...
Adenosquamous lung tumours, which are extremely poor prognosis, may result from cellular plasticity....
Circulating tumour cells (CTCs) serve as valuable biomarkers. However, EpCAM positive CTCs are less ...
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, pl...
Small cell lung cancer (SCLC) is treated as a homogeneous disease, although the expression of NEUROD...
Small Cell Lung Cancer (SCLC) is a devastating disease characterized by a very low two-year survival...
Small cell lung cancer (SCLC) patient-derived xenografts (PDX) can be generated from biopsies or cir...
Background: Cancer stem cells (CSCs) are thought to be responsible for tumor regeneration after chem...
Identification of the cellular and molecular aspects of lung cancer stem cells (LCSCs) that are sugg...
In recent years, studies of cancer development and recurrence have been influenced by the cancer ste...
The lack of inadequate preclinical models remains a limitation for cancer drug development and is a ...
Knowledge on the molecular mechanisms underlying metastasis colonization in Non-Small Cell Lung Canc...
Recent evidences suggest that stearoyl-CoA-desaturase 1 (SCD1), the enzyme involved in monounsaturat...
In recent years studies of cancer development and recurrence have been significantly influenced by t...
Breast cancer tumors display different cellular phenotypes. A growing body of evidence points toward...
Cancer stem cell (CSC) theory states that tumors are organized in a similar hierarchical manner as n...
Adenosquamous lung tumours, which are extremely poor prognosis, may result from cellular plasticity....
Circulating tumour cells (CTCs) serve as valuable biomarkers. However, EpCAM positive CTCs are less ...
© The Author(s) 2019. Published by Oxford University Press. All rights reserved. For permissions, pl...
Small cell lung cancer (SCLC) is treated as a homogeneous disease, although the expression of NEUROD...
Small Cell Lung Cancer (SCLC) is a devastating disease characterized by a very low two-year survival...
Small cell lung cancer (SCLC) patient-derived xenografts (PDX) can be generated from biopsies or cir...